Puma Biotechnology Inc - Common Stock — datos financieros trimestrales (NASDAQ:PBYI) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas 15.61 M3.61 M14.08 M9.69 M14.42 M15.42 M 53.61 M Flujo de caja de las actividades de inversión -2.32 M1.53 M-11.25 M506 K-26.98 M2.47 M -35.24 M Flujo de caja de las actividades financieras -11.33 M-11.33 M-11.2 M-11.33 M-11.33 M-11.33 M -45.2 M Flujo de caja libre 15.61 M3.61 M14.06 M9.66 M14.46 M15.42 M 53.6 M

Puma Biotechnology Inc - Common Stock

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Noticias

PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised

Puma Biotechnology, Inc. (PBYI) Q1 2026 Earnings Call Transcript

Puma Biotechnology, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-05-08

Informe de resultados de Puma Biotech Q1 2026: BPA e ingresos por debajo de las previsiones

Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Beats Revenue Estimates

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?

Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?

Puma Biotechnology 4T 2025: ingresos de NERLYNX suben 15%

Puma Biotechnology reporta sólidos resultados del cuarto trimestre de 2025

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?